Compared to the control group, the mRNA expression levels of C-X-C motif chemokine ligand 10 (CXCL10), C-C motif chemokine ligand 2 (CCL2), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and (CXCL2)were significantly upregulated in the livers of the NAFLD group. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatotic liver disease.